Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Advanced Solid Tumor × Sirolimus × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 31 Myelodysplastic Syndromes 27 Leukemia, Myeloid, Acute 27 Hodgkin Disease 24 Lymphoma, Non-Hodgkin 23 Multiple Myeloma 22 Lymphoma 20 Leukemia 20 Graft vs Host Disease 20 Leukemia, Lymphocytic, Chronic, B-Cell 19 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 15 Myeloproliferative Disorders 14 Lymphoma, Mantle-Cell 14 Tuberous Sclerosis 12 Neoplasms 12 Lymphoma, Large B-Cell, Diffuse 12 Hematologic Neoplasms 12 Burkitt Lymphoma 12 Primary Myelofibrosis 11 Recurrence 10 Neoplasms, Plasma Cell 10 Lymphoma, Follicular 10 Leukemia, Myelomonocytic, Chronic 10 Waldenstrom Macroglobulinemia 9 Sarcoma 9 Neoplasm Metastasis 9 Lymphoma, B-Cell, Marginal Zone 9 Lymphangioleiomyomatosis 9 Leukemia, Myeloid, Chronic-Phase 9 Leukemia, Myeloid, Accelerated Phase 9

Interventions

toripalimab 5 tislelizumab 3 spartalizumab 2 pembrolizumab 2 camrelizumab 2 Injections 2 Immune Checkpoint Inhibitors 2 Drug Therapy 2 sintilimab 1 penpulimab 1 olaparib 1 lenvatinib 1 fludarabine 1 conteltinib 1 atezolizumab 1 anlotinib 1 adagrasib 1 Sorafenib 1 Sirolimus 1 Paclitaxel 1 Oxaliplatin 1 Metformin 1 Magnetic Resonance Spectroscopy 1 Leucovorin 1 Irinotecan 1 Inosine 1 Immunotherapy 1 Gemcitabine 1 Fluorouracil 1 Cyclophosphamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00509613 2009-09-18

Phase 1 Study With Sorafenib and Sirolimus

Radboud University Medical Center

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡